These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 29384065)

  • 1. IGF-1R Inhibitor Ameliorates Diabetic Nephropathy with Suppressed HMGN1/TLR4 Pathway.
    Yu J; Da J; Dong R; Sun Y; Nie Y; Yu F; Zuo L; Zha Y
    Endocr Metab Immune Disord Drug Targets; 2018; 18(3):241-250. PubMed ID: 29384065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Mobility Group Nucleosome-Binding Protein 1 Mediates Renal Fibrosis Correlating with Macrophages Accumulation and Epithelial-to-Mesenchymal Transition in Diabetic Nephropathy Mice Model.
    Yu J; Dong R; Da J; Li J; Yu F; Zha Y
    Kidney Blood Press Res; 2019; 44(3):331-343. PubMed ID: 31203283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophosphatidic acid receptor 1 inhibitor, AM095, attenuates diabetic nephropathy in mice by downregulation of TLR4/NF-κB signaling and NADPH oxidase.
    Lee JH; Sarker MK; Choi H; Shin D; Kim D; Jun HS
    Biochim Biophys Acta Mol Basis Dis; 2019 Jun; 1865(6):1332-1340. PubMed ID: 30763641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Berberine ameliorates diabetic nephropathy by inhibiting TLR4/NF-κB pathway.
    Zhu L; Han J; Yuan R; Xue L; Pang W
    Biol Res; 2018 Mar; 51(1):9. PubMed ID: 29604956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMGN1 down-regulation in the diabetic kidney attenuates tubular cells injury and protects against renal inflammation via suppressing MCP-1 and KIM-1 expression through TLR4.
    Yu J; Da J; Yu F; Yuan J; Zha Y
    J Endocrinol Invest; 2024 Apr; 47(4):1015-1027. PubMed ID: 38409569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin deficiency induces rat renal mesangial cell dysfunction via activation of IGF-1/IGF-1R pathway.
    Kong YL; Shen Y; Ni J; Shao DC; Miao NJ; Xu JL; Zhou L; Xue H; Zhang W; Wang XX; Lu LM
    Acta Pharmacol Sin; 2016 Feb; 37(2):217-27. PubMed ID: 26775660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Inhibitory Effect of Rapamycin on Toll Like Receptor 4 and Interleukin 17 in the Early Stage of Rat Diabetic Nephropathy.
    Yu R; Bo H; Villani V; Spencer PJ; Fu P
    Kidney Blood Press Res; 2016; 41(1):55-69. PubMed ID: 26849067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor of IGF1 receptor alleviates the inflammation process in the diabetic kidney mouse model without activating SOCS2.
    Li J; Dong R; Yu J; Yi S; Da J; Yu F; Zha Y
    Drug Des Devel Ther; 2018; 12():2887-2896. PubMed ID: 30254418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant fibrous histiocytoma amplified sequence 1 alleviates inflammation and renal fibrosis in diabetic nephropathy by inhibiting TLR4.
    Lian H; Cheng Y; Wu X
    Biosci Rep; 2019 Nov; 39(11):. PubMed ID: 31696221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IGF-1/IGF-1R blockade ameliorates diabetic kidney disease through normalizing Snail1 expression in a mouse model.
    Dong R; Yu J; Yu F; Yang S; Qian Q; Zha Y
    Am J Physiol Endocrinol Metab; 2019 Oct; 317(4):E686-E698. PubMed ID: 31361542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined therapy of rhein and benazepril on the treatment of diabetic nephropathy in db/db mice.
    Jia ZH; Liu ZH; Zheng JM; Zeng CH; Li LS
    Exp Clin Endocrinol Diabetes; 2007 Oct; 115(9):571-6. PubMed ID: 17943690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amelioration of Diabetic Mouse Nephropathy by Catalpol Correlates with Down-Regulation of Grb10 Expression and Activation of Insulin-Like Growth Factor 1 / Insulin-Like Growth Factor 1 Receptor Signaling.
    Yang S; Deng H; Zhang Q; Xie J; Zeng H; Jin X; Ling Z; Shan Q; Liu M; Ma Y; Tang J; Wei Q
    PLoS One; 2016; 11(3):e0151857. PubMed ID: 26986757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy.
    Jheng HF; Tsai PJ; Chuang YL; Shen YT; Tai TA; Chen WC; Chou CK; Ho LC; Tang MJ; Lai KT; Sung JM; Tsai YS
    Dis Model Mech; 2015 Oct; 8(10):1311-21. PubMed ID: 26398934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of Tangshenling Mixture and benazepril on rats with diabetic nephropathy and its mechanism].
    He XL; Li JP; Chen YP; Zhang ZG; Lin WQ; Chen JH
    Zhong Xi Yi Jie He Xue Bao; 2006 Jan; 4(1):43-7. PubMed ID: 16409969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ; Wang Y; Li Q; Tian YJ; Liu MH; Yu YH
    Chin Med J (Engl); 2006 May; 119(10):814-21. PubMed ID: 16732983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dioscin protects against diabetic nephropathy by inhibiting renal inflammation through TLR4/NF-κB pathway in mice.
    Cai S; Chen J; Li Y
    Immunobiology; 2020 May; 225(3):151941. PubMed ID: 32359778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ramipril can alleviate the accumulation of renal mesangial matrix in rats with diabetic nephropathy by inhibiting insulin-like growth factor-1.
    Ren W; Zhao C; Wang Y; Fang Y; Huang Z; Chen W; Wang L; Hu W; Wang K; Ni L
    Acta Cir Bras; 2019 Feb; 34(1):e20190010000007. PubMed ID: 30785508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice.
    Kuwabara T; Mori K; Mukoyama M; Kasahara M; Yokoi H; Saito Y; Ogawa Y; Imamaki H; Kawanishi T; Ishii A; Koga K; Mori KP; Kato Y; Sugawara A; Nakao K
    Diabetologia; 2012 Aug; 55(8):2256-66. PubMed ID: 22610400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Andrographolide ameliorates diabetic nephropathy by attenuating hyperglycemia-mediated renal oxidative stress and inflammation via Akt/NF-κB pathway.
    Ji X; Li C; Ou Y; Li N; Yuan K; Yang G; Chen X; Yang Z; Liu B; Cheung WW; Wang L; Huang R; Lan T
    Mol Cell Endocrinol; 2016 Dec; 437():268-279. PubMed ID: 27378149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination against type 1 angiotensin receptor prevents streptozotocin-induced diabetic nephropathy.
    Ding D; Du Y; Qiu Z; Yan S; Chen F; Wang M; Yang S; Zhou Y; Hu X; Deng Y; Wang S; Wang L; Zhang H; Wu H; Yu X; Zhou Z; Liao Y; Chen X
    J Mol Med (Berl); 2016 Feb; 94(2):207-18. PubMed ID: 26407577
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.